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ABSTRACT
Introduction One in five patients undergoing total knee 
arthroplasty (TKA) experience unchanged or worse pain 
and physical function 1 year after surgery. Identifying risk 
factors for unfavourable outcomes is necessary to develop 
tailored interventions to minimise risk. There is a need to 
review more current literature with updated methodology 
that addresses the limitations of earlier systematic 
reviews and meta- analyses. We present a Preferred 
Reporting Items for Systematic Review and Meta- Analysis 
Protocols compliant protocol for a systematic review and 
meta- analysis of predictors of chronic pain and impaired 
function after TKA.
Methods and analysis This review will include 
prospective longitudinal observational studies, or 
randomised trials (including cluster and crossover designs) 
that report arm- wise predictors of chronic postsurgical 
pain or impaired physical function at 3 months, 6 months 
or 12 months. A comprehensive literature search of studies 
published between 2000 and 2019 will be performed in 
Medline, Embase, CINAHL, Cochrane Library and PEDro. 
Blinded assessment with consensus agreement will 
be applied for inclusion of studies, data extraction and 
assessment of bias risk (Quality in Prognosis Studies tool). 
The co- primary outcomes, pain and impaired function, 
at 12 months after TKA will be analysed separately. 
Estimates of association between each outcome and any 
preoperative or intraoperative factor that may predict 
chronic pain or impaired physical function will be extracted 
from the included studies, where possible. For randomised 
studies, results will only be extracted from TKA arms (or 
the first period of crossover trials). Estimates of association 
from the primary evidence will be synthesised narratively, 
and quantitatively using multivariate meta- analysis to 
provide ‘pooled’ estimates of association. Subgroup 
and sensitivity analyses will be performed. Certainty 
of evidence for each predictor will be derived from the 
Grading of Recommendations Assessment, Development 
and Evaluation framework.
Ethics and dissemination No ethical issues are 
associated with this project. The results from this review 
will be published in peer- reviewed journals and presented 
at international conferences.
PROSPERO registration number CRD42018079069.
INTRODUCTION
Total knee arthroplasty (TKA) is a common 
surgical procedure for patients with osteoar-
thritis (OA) suffering from pain and impaired 
function.1 2 In the United Kingdom and the 
Isle of Man, nearly 100 000 primary TKAs 
are performed annually,3 while the number 
for the USA is 700 000.4 Despite advances in 
anaesthesia and the surgical field, such as 
implementation of fast track surgery, 20% of 
TKA patients experience pain and levels of 
physical function that remains unchanged or 
Strengths and limitations of this study
 ► The strengths of this review include a transparent 
protocol with rigorous and updated methodology 
throughout each phase of the review process, a 
comprehensive literature search with no limitations 
on predictors or language, and inclusion of only the 
strongest observational study designs to avoid ex-
cessive heterogeneity and a thorough description of 
the data analysis plan.
 ► Use of consistent methods for assessing the risk 
of bias (Quality in Prognosis Studies tool) and cer-
tainty of evidence (Grading of Recommendations 
Assessment, Development and Evaluation frame-
work) is also a study strength.
 ► Since 95% of patients treated with total knee ar-
throplasty suffer from osteoarthritis, results will 
have high generalisability within the osteoarthritis 
population, but results might be less applicable to 
other populations, such as adults or children with 
rheumatoid arthritis.
 ► The validity of the results of this systematic review 
and meta- analysis will depend on the quality of the 
published studies included, the definitions applied 
for chronic pain or impaired physical function and 
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worse 1 year after surgery.5–7 Unfavourable outcomes can 
seriously impact patients through further deterioration 
in health status8 9 and dissatisfaction with postoperative 
rehabilitation and surgical outcomes.9–12 Patients who do 
not benefit from surgery are also more likely to undergo 
revision surgery,3 13 14 have higher healthcare utilisation 
and are less likely to return to work.10 15–17 Consequently, 
poor TKA outcomes represent a significant burden, on a 
personal level to the individual patient and family level, 
as well as on a socioeconomic level, with considerable 
healthcare resources being spent on ineffective TKA 
procedures.18
One strategy to reduce the burden of poor TKA 
outcomes, for individual patients and society, is to gain 
a better understanding of the preoperative and intraop-
erative predictors of chronic pain and impaired function 
after TKA. Knowledge of preoperative and intraoperative 
risk factors is a fundamental first step in the development 
of screening tools to identify patients at high risk for 
chronic pain or impaired function after TKA. Identifying 
such patients would allow targeted and tailored inter-
ventions to be developed in order to improve patients’ 
surgical outcomes.19 20 Early identification of patients at 
high risk can also provide both patients and clinicians 
with more personalised information about the risks of 
surgery during the decision- making process when consid-
ering TKA.
During the last decade, a considerable number of 
hypothesised preoperative predictors of chronic pain 
and poor function after TKA have been investigated 
(figure 1). Systematic reviews and meta- analyses exist,21–34 
but have yielded contradictory findings. This could be 
due to the use of methods that deviate from what is now 
understood to be a good practice, as codified by the 
Preferred Reporting Items for Systematic Reviews and 
Meta- Analysis (PRISMA) statement,35 and the recently 
updated Cochrane Handbook.36 The existing reviews are 
also more than 5 years old,21–27 and several new studies 
have been published in the interim.
Thus, a new synthesis of the literature that uses 
evidence- based methods is warranted to better inform 
patients, clinicians, researchers and policy- makers 
about risk factors for patient outcomes of chronic pain 
and impaired physical function after TKA. The study 
described in this protocol will investigate outcomes that 
earlier reviews did not address and use systematic review 
and meta- analysis tools that were not available when prior 
reviews were published. This systematic review and meta- 
analysis will be conducted according to state- of- the- art 
evidence- based methods (as outlined by Cochrane), and 
Figure 1 Hypothesised preoperative and intraoperative predictors of chronic pain and poor function after total knee 
arthroplasty. ASA score, The American Society of Anesthesiologists score; CAS, computer assisted surgery; OA severity, 







ber 17, 2020 at H








pen: first published as 10.1136/bm






3Olsen U, et al. BMJ Open 2020;10:e037674. doi:10.1136/bmjopen-2020-037674
Open access
will cover two related, yet distinct outcomes: pain and 
function. Gaps in knowledge will be addressed, that will be 
useful for researchers in exploring areas that have previ-
ously received little research attention. Thus, the aim of 
this study is to conduct a systematic review and synthesis 
of current evidence. The result of this work will include a 
narrative description of the factors identified, and a statis-
tical meta- analysis that provides point estimates and 95% 
CIs of the strength of association between each preoper-
ative and intraoperative factor evaluated by the included 
studies, and the co- primary outcomes of chronic pain and 
impaired function following TKA at short- term, medium- 
term and long- term follow- ups (3 months, 6 months and 
12 months).
METHODS AND ANALYSISS
This systematic review and meta- analysis will include two 
key outcomes, chronic pain and impaired physical func-
tion, which are moderately to strongly associated, but 
distinct.37 Thus, chronic pain and impaired function 
will be assessed and reported as two separate outcomes. 
Our strategy is consistent with the Cochrane Handbook 
for Systematic Reviews of Interventions,36 which suggests 
that a review may start with a broad scope before being 
divided into more narrow reviews.
This protocol has been developed according to the 
Preferred Reporting Items for Systematic Review and 
Meta- Analysis Protocols checklist and the review will be 
reported according to the PRISMA guidelines.35 The 
described study will be guided by the biopsychosocial 
framework,38 found suitable for OA39 and TKA patients.40 
This model takes into account the complex interplay 
between biological, psychological and social factors when 
understanding health condition and outcomes following 
TKA surgery for OA. The framework is operationalised 
in figure 1.
Eligibility criteria for considering studies in this review
Prospective longitudinal observational studies or the TKA 
arm of randomised trials (including cluster and cross-
over designs) of OA patients undergoing primary TKA 
and that report at least one preoperative or intraopera-
tive predictor of chronic postsurgical pain or impaired 
function (measured 3 months, 6 months or 12 months 
after primary TKA) will be considered for inclusion. 
The data from non- TKA arms will be excluded because 
we are only interested in associations between predic-
tors and outcomes in patients treated with TKA (we are 
not interested in predicting pain or function for other 
treatments, nor are we interested in the relative effects 
of TKA vs other interventions). For crossover trials, only 
the first period of the TKA arm will be included to avoid 
carryover effects. Studies of unicompartmental surgery, 
studies without separate outcome data for TKA patients, 
studies that lack clear pain and physical function outcome 
measures, retrospective studies and case–control studies 
will be excluded.
The eligibility criteria are pre- specified by the Popu-
lation–Exposure–Outcome–Study (PEOS) design, as 
described below.
Population: patients 18 years or older with OA and 
scheduled for primary TKA.
Exposures: any preoperative or intraoperative factors 
that may predict chronic pain and impaired physical 
function in TKA patients.
Outcome: the two co- primary outcomes are pain and 
function assessed 12 months after TKA. Where possible, 
these outcomes will also be analysed at 3 months’s and 6 
month’s after TKA.
Study design: a prospective longitudinal observational 
design, or a randomised trial design (including cluster 
and crossover designs).
Timeline
The timeline for the study phases is shown in table 1. The 
research question has been specified, protocol details 
have been registered and published, the search has been 
performed and formal screening of the search results 
against eligibility criteria is in progress. Full- text inclusion 
is ongoing.
Review question
The review question is: ‘which factors predict chronic 
pain and impaired physical function among patients after 
TKA?’.
Definitions
Chronic/persistent pain is defined as pain extending 3 
months after TKA.41 Physical function refers to all body 
functions, activities and participation according to the 
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International Classification of Functioning, Disability and 
Health framework.42
Chronic pain and impaired physical function can be 
measured in various ways and questionnaires (table 2), 
including as a continuous variable that represents a 
continuum of pain (eg, a score on a Visual Analogue 
Scale) or as a categorical variable (eg, a dichotomous 
variable with categorical levels of ‘chronic pain’ or ‘no 
chronic pain’). Similarly, physical function can be assessed 
on a continuum (eg, as indicated by the Knee Injury and 
Osteoarthritis Outcome Score) or as different categories 
of function (eg, ‘no problems walking’, ‘some problems 
walking’ and ‘confined to bed’, as in EQ 5D 3L).
Literature search strategy
The search strategy was developed by two medical librar-
ians (Gunn Kleven and Hilde Flaaten) in cooperation 
with the authors (UO and MFL) and with input from 
the experienced research team. The search strategy was 
designed by one research librarian (Gunn Kleven) and 
peer reviewed by the second research librarian (Hilde 
Flaaten) and first author (UO), as recommended by 
the Cochrane Handbook.36 A comprehensive systematic 
search for articles published from 1 January 2000 through 
1 August 2019 was conducted (Gunn Kleven) using a 
combination of text words and database- specific subject 
headings in Medline (Ovid), Embase (Ovid), CINAHL 
(EBSCO), Cochrane Library and Physiotherapy Evidence 
Database. The search strategies were adapted to each 
database as presented in online supplementary material.
To capture as many relevant studies as possible, no 
language restrictions were applied, as recommended in 
Methodological Expectations of Cochrane Intervention 
Reviews (MECIR) standards.43 The search was limited 
to studies published in or after year 2000 in consider-
ation of changes in treatment modalities since year 2000. 
Duplicates were removed and conference abstracts were 
excluded. Studies had to be available in full- text format. 
References were imported to EndNote V.X8 (Clarivate 
Analytics, Philadelphia, Pennsylvania, USA).
Study selection and data extraction
To avoid missing relevant articles, an overly inclusive 
approach for screening titles, abstracts and full text will 
be used. Publication abstracts in non- English and non- 
Scandinavian languages will be translated and assessed 
for eligibility. Both screening and selecting studies for 
full- text review will include independent and blinded 
screening by two authors (UO and MFL), with consensus 
discussion to resolve disagreements. If consensus cannot 
be reached, a third reviewer will adjudicate (EM- LD). 
Studies that fulfil the eligibility criteria will be retained, 
fully translated and scrutinised for full- text assessment 
against eligibility criteria. A standardised data extraction 
form customised to the research question will be devel-
oped for extraction of data and pilot- tested on the first 
three included studies (table 3). If additional data are 
needed about a particular study, the corresponding and/
Table 3 Data extraction template
Data Extracted data
Publication details First author and senior author, year of publication and country of origin
Study characteristics Study design (prospective longitudinal observational design; intervention arm of a randomised trial; 
and intervention arm of the first period of a randomised crossover trial), source of patient recruitment, 
length of follow- up, sample size, statistical method and results
Patients characteristics Age, sex, body mass index, ethnicity, socioeconomics and demographics
Intervention Type of implant and anaesthetic and analgesic factors
Predictors Type of predictors and how they are measured, for example, pain by Brief Pain Inventory, depression 
by Hospital Anxiety Depression Scale, severity of osteoarthritis by Kellgren Lawrence Scale and 
direction of effect (reversed or not)




Analysis type (eg, linear regression or correlation coefficient), estimate (ie, numerical result) and 
precision (eg, CI, SE, p value)
Table 2 Outcomes and how they could be measured in the 
included studies
Measures of the chronic 
pain outcome
Measures of the physical 
function outcome
Western Ontario and 
McMaster Universities 
Osteoarthritis Index
Western Ontario and 
McMaster Universities 
Osteoarthritis Index
Knee Society Score Knee Society Score
Knee Injury and Osteoarthritis 
Outcome Score
Knee Injury and Osteoarthritis 
Outcome Score
Short Form 36 Short Form 36
Oxford Knee Score Oxford Knee Score
McGill Pain Questionnaire Timed Up and Go Test
Brief Pain Inventory Sit to Stand Test
Numerical Rating Scale Range of Motion








ber 17, 2020 at H








pen: first published as 10.1136/bm






5Olsen U, et al. BMJ Open 2020;10:e037674. doi:10.1136/bmjopen-2020-037674
Open access
or senior authors of the publication will be contacted to 
obtain more detail.
It is anticipated that included studies may present 
multiple results for each predictor (eg, several regres-
sion models resulting from stepwise model- building 
procedures). The data will be extracted for the model 
or analysis specified as the primary analysis in the study 
protocol; if no suitable model or analysis is specified, we 
will extract data for the model or analysis favoured by 
the study’s authors and presented as the ‘main result’ 
or ‘full model’ (eg, the model with the best goodness 
of fit criteria, such as Akaike’s information criterion).44 
A consensus- based approach will be used to determine 
which result is favoured by a study (ie, two authors 
performing data extraction must agree; in the event of 
disagreement, a third author will adjudicate). Acquisi-
tion and analysis of individual patient- level data (IPD) 
is not planned. For example, we will not re- analyse IPD 
with respect to our own definitions of the co- primary 
outcomes.
Studies may use different names for the same predictor. 
Predictors will be considered to be the same, if they are 
measured using the same method (eg, instrument), or 
if the methods of measurement are judged to assess the 
same construct (eg, anxiety) by two authors (in the event 
of disagreement, a third author will adjudicate).
Variables of interest measured before TKA and included 
in pre- specified or ‘main’ analyses will be extracted and 
included in meta- analyses. Studies may report estimates 
adjusted for variables such as age, sex and presurgical 
pain, as well as unadjusted estimates. Because we are inter-
ested in predictors’ independent value over and above 
other predictors, we will extract estimates from adjusted 
models (even if some available predictors were excluded 
from the ‘final’ model, eg, as a result of a model- building 
approach; estimates for omitted predictors will be treated 
as missing as described below).
For randomised trials, data will be extracted for the TKA 
arm and treated in the same way as longitudinal obser-
vational data. For crossover trials, data will be extracted 
from the first period of the TKA arm and will be treated 
similarly. Because cluster designs will be included, we will 
extract the unit of analysis used for all studies (patient vs 
cluster). If studies that use a cluster design report results 
that do not account for possible cluster effects, we will 
impute results that adjust for clustering where feasible; if 
it is not feasible to adjust for clustering, we will judge the 
study to have a high risk of bias (see below). It is antici-
pated that publications that report randomised designs 
may not provide arm- wise results. We will contact authors 
of such studies and request the required data; studies will 
be excluded from synthesis if data are not received within 
4 weeks of request.
If associations are reported for multiple levels of an 
ordinal predictor (eg, associations between pain and over-
weight vs normal weight, and obese vs normal weight), we 
will extract data for the most extreme comparison (obese 
vs normal weight, in this example).
Measures of association
Based on a scoping exercise, studies may report estimates 
of association between categorical or continuous predic-
tors and outcomes. Association may be quantified using 
odds or risk ratios, linear model coefficients (including 
differences) and correlation coefficients. Furthermore, 
base cases of categorical variables may vary, as may direc-
tions of association. We will define canonical directions of 
association and measure association using the correlation 
coefficient, which is defined to be invariant under linear 
transformations of predictor and outcome variables and, 
under reasonable assumptions, can be imputed for all 
combinations of dichotomous and continuous predictors 
and outcomes (see online supplementary methods). If it 
is necessary to impute ORs from risk ratios, we will assume 
a baseline probability of postsurgical pain and impaired 
function of 20%. Meta- analysis will be performed by 
transforming correlation coefficients using Fisher’s z 
transformation.45 This approach is similar to that used in 
a previous review on this topic by Lewis et al.27
Methodological quality
To systematically evaluate study quality and to reach 
consensus in a transparent manner, the Quality in Prog-
nosis Studies (QUIPS) tool will be used to assess risk of 
bias in the individual studies.46 QUIPS tool addresses six 
domains where bias may occur in prognostic studies: study 
participation, attrition, prognostic factor measurement, 
outcome measurement, confounding and statistical anal-
ysis and reporting.36 Two authors (UO and MFL) must 
agree, otherwise a third reviewer (EM- LD) will adjudicate.
Dealing with missing data
Study authors will be contacted if there is a need for addi-
tional details about unpublished data, as recommended 
by the Cochrane Handbook.36 Requests will be sent to 
a study’s corresponding author and the first or senior 
author if the corresponding author cannot be contacted. 
In addition, critical appraisal will be carried out and 
reported regarding study participant attrition, losses to 
follow- up or withdrawal and any issues regarding missing 
data or imputation methods (eg, last observation carried 
forward).
It is anticipated that not all included studies will report 
associations between outcomes and all predictors that 
have been studied in the literature as a whole (ie, the 
nature of the research question suggests that estimates 
for some predictors may be missing for most studies). 
This form of missing data will be addressed in a meta- 
analysis, as described in the data synthesis section.
It is assumed that some included studies will report 
point estimates but not exact statements of uncertainty 
on those estimates (eg, some studies may report results 
as ‘statistically significant’ rather than providing an exact 
p value or CI). A conservative approach will be used in 
which ‘worst case’ standard errors will be imputed: results 
reported as ‘statistically significant’ (eg, p≤0.05) will be 
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results reported as ‘not statistically significant’ (eg, 
p>0.05) will be imputed to have standard errors consis-
tent with p=0.99.
Data synthesis
A narrative analysis of the results will be conducted for 
all included studies for the two co- primary outcomes at 
12 months. Meta- analyses will be performed for the two 
co- primary outcomes of chronic pain and impaired phys-
ical function assessed 3 months and 6 months after the 
surgery, if possible.
Where possible, we will perform quantitative data 
synthesis following the guidance of the most recent 
version of the Cochrane Handbook available at the time 
of the analysis.36 If meta- analysis cannot be performed, we 
will conduct a narrative analysis.
It is anticipated that predictors may be correlated and 
that there may be important differences in the methods 
used to quantify associations between outcomes and 
predictors (ie, while the methods used in the included 
studies will attempt to measure compatible constructs, 
they are likely to be sufficiently different that we expect 
heterogeneity). Multivariate meta- analysis will, there-
fore, be performed for each outcome using a random- 
effects model. Analyses will be performed using Stata V.16 
(StataCorp LLC, College Station, Texas, USA) and the 
MVMETA command or R and the metafor package.47–49 
Missing point estimates for predictors not included in 
individual studies will be handled using the standard 
procedures defined by the software used. For example, 
the MVMETA command models missing point estimates 
as zeros and accounts for uncertainty using very large 
variances (ie, missing point estimates could plausibly take 
any value). Within- study correlations will be assumed to 
be unknown and the ‘overall correlation model’ of Riley 
et al50 will be used. An unstructured between- study cova-
riance matrix will be assumed. If negligible correlations 
are inferred, we may report univariate meta- analyses by 
predictor.
Assessment of non-reporting bias and small-study effects
Non- reporting bias and small study effects will be assessed 
following the approach outlined by Sterne et al.51 For 
each predictor supported by at least 10 results, contour- 
enhanced funnel plots will be constructed by plotting 
Fisher’s Z against its SE. Funnel plot asymmetry will be 
judged visually and tested using Egger’s regression- based 
test (at the α=0.05 level) assuming random effects. Predic-
tors for which asymmetry is suspected will be reported 
with consideration for the possible causes of asymmetry. 
In particular, asymmetry will not be definitively attributed 
to non- reporting bias because it may have other expla-
nations. Fixed- effects and random- effects meta- analysis 
estimates will not be compared because we anticipate 
heterogeneity and, therefore, judge that the fixed- effects 
model is inappropriate. Predictors will not be excluded 
from meta- analysis on the basis of suspected asymmetry 
but will be downgraded for certainty of evidence (see 
below).
Assessment of heterogeneity
Clinical and methodological heterogeneity will be eval-
uated subjectively. We will interpret I2 values following 
guidelines in the Cochrane Handbook36 and Grading 
of Recommendations Assessment, Development and 
Evaluation (GRADE) framework.52 Exploratory analyses 
may be performed to attempt to explain any substantial 
heterogeneity.
Subgroup analysis
Exploratory subgroup meta- analyses will be performed 
for the two co- primary outcomes with respect to study 
design, type of outcome measurement and intervention 
(eg, type of implant). Subgroup analyses will only be 
performed if at least 10 studies can be included in each 
subgroup.
Sensitivity analysis
We will perform exploratory sensitivity analyses for the 
two co- primary outcomes. For each of the six QUIPS tool’s 
bias domains, we will perform meta- analyses by excluding 
studies judged to be at high risk of bias and compare 
meta- analysis results to those obtained when all studies 
are included. We will compare meta- analysis results when 
pain and impaired physical function are modelled as two 
separate outcomes versus a single multivariate outcome 
(ie, a single multivariate model of the two co- primary 
outcomes will also be fitted). We will assess the influence 
of individual studies on meta- analytical results via leave- 
one- out analysis.
Certainty of evidence using the GRADE framework
The certainty of evidence for each prognostic factor will 
be derived using the GRADE framework for prognostic 
studies.46 53 54 Study limitations, indirectness, inconsis-
tency, imprecision, publication bias, magnitude of associ-
ation, dose–response gradient and plausible confounding 
affecting confidence will be evaluated.46 The overall 
certainty of evidence will be rated as high, moderate, low 
or very low. GRADE ratings will be assigned by two of the 
authors (UO and MFL), issues will be discussed to arrive 
at consensus and if not, a third reviewer (EM- LD) will 
adjudicate.
Presentation and interpretation of results
Search strategy results will be presented, as well as charac-
teristics of included studies, descriptive data for the eligi-
bility criteria according to the PEOS design template data 
extraction form, data dictionary document, judgement of 
risk of bias by QUIPS and the GRADE evidence profile.
Funnel plots will be used for assessing presence of 
publication bias for the two separate outcomes. The 
meta- analytical result for each outcome will be presented 
as forest plots. For example, one forest plot will present 
meta- analytical point estimates and 95% CI and prediction 
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probability of being the best predictor (eg, via the ‘pbest’ 
option of MVMETA); additional forest plots may show 
results for each predictor, showing the results extracted 
from the included studies and the meta- analytical point 
estimates and 95% CI and prediction intervals.
Following MECIR standards,43 meta- analytical results 
will be re- expressed as correlation coefficients to facilitate 
interpretation. We will provide layperson interpretations 
of these in summary of findings’ tables using Cohen’s 
labels ‘small’ (correlation=0.1), ‘weak’ (0.3) and ‘large’ 
(0.5).
Meta- analytical results will be presented in a summary 
of findings table for each outcome56 with columns for: 
predictor; meta- analytical result (Fisher’s Z and its 95% 
CI); re- expressed Fisher’s Z and its 95% CI; a layperson 
interpretation of the magnitude of association; number 
of participants (and clusters, where appropriate) and 
number of studies; certainty of evidence (GRADE) and 
comments.
Subgroup and sensitivity analyses, and meta- analyses of 
predictors of chronic pain and impaired physical function 
measured at 3 months and 6 months after TKA, will be 
narratively summarised from any available reported data. 
Tables and figures for these analyses will be presented in 
an appendix.
Factors identified as being associated with the co- pri-
mary outcomes will not be interpreted to cause those 
outcomes because the included study designs and planned 
analyses do not allow causal inferences to be made.
Deviations from protocol
Deviations from this protocol will be reported and 
justified.
Patient and public involvement
No patients will be involved in this review.
Strengths and limitations
By following the Cochrane Handbook’s method recom-
mendations36 throughout each phase, we aim to achieve a 
high- quality review that will be of importance to patients, 
clinicians, researchers and policy- makers. To provide 
reliable data to address the review’s aim and to avoid 
excessive heterogeneity caused by different study designs 
that might affect robustness of the review’s results or 
introduce high risk of bias, only prospective longitudinal 
studies or the intervention arm of randomised trials will 
be included. No language limitations will be applied so 
that relevant studies are not excluded, thereby increasing 
precision of the findings and maximising generalisability. 
As a result, widespread application of the study results 
is expected. Although postoperative predictors may be 
important for non- improvement after TKA surgery, this 
will not be covered by this study’s aim. QUIPS and GRADE 
will be used to assess risk of bias for individual studies and 
assess certainty of evidence of included studies. Since 
95% of patients treated with TKA suffer from OA, results 
will have high generalisability within the OA population, 
but might be less applicable to other populations, such 
as patients with rheumatoid arthritis. The strict eligibility 
criteria exclude studies that only report outcomes after 
1 year; most registered studies will be rejected as they 
are less likely to be prospective. Results must be inter-
preted based on this study context. We might find that 
predictors and outcomes are measured quite differently 
across studies. However, an effect size for a meta- analysis 
creates a standardised measure so the actual measure 
scaling is not relevant and thus a meta- analysis is perfect 
for reviewing studies that use different measures for the 
same conceptual outcome.
Ethics and dissemination
Primary data will not be collected, thus ethical approval 
is not required. Results will be presented at international 
conferences, and findings will be published in peer- 
reviewed high- impact journals and a doctoral thesis.
User involvement
Members from the user board at Lovisenberg Diaconal 
Hospital, Jan Otto Veiseth and Richard Madsen, have 
been contributing to the relevance and significance of 
the protocol’s content.
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